Limited Clinical Significance of Splenectomy and Splenic Hilar Lymph Node Dissection for Type 4 Gastric Cancer |
Kunitomo, Aina
(Department of Gastroenterological Surgery, Aichi Cancer Center Hospital)
Misawa, Kazunari (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Ito, Yuichi (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Ito, Seiji (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Higaki, Eiji (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Natsume, Seiji (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Kinoshita, Takashi (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Abe, Tetsuya (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Komori, Koji (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) Shimizu, Yasuhiro (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) |
1 | Nakamura K. Issues focused on the IIc lesion in adenocarcima of fundic gland area: from the landscape of "a way to linitis plastica". Stomach Intest 1987;22:999-1001. |
2 | Agnes A, Estrella JS, Badgwell B. The significance of a nineteenth century definition in the era of genomics: linitis plastica. World J Surg Oncol 2017;15:123. DOI |
3 | Okajima K, Isozaki H. Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg 1995;19:537-540. DOI |
4 | Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T. Clinical significance of splenic hilar dissection with splenectomy in advanced proximal gastric cancer: an analysis at a single institution in Japan. World J Surg 2016;40:1165-1171. DOI |
5 | Pedrazzani C, Marrelli D, Pacelli F, Di Cosmo M, Mura G, Bettarini F, et al. Gastric linitis plastica: which role for surgical resection? Gastric Cancer 2012;15:56-60. DOI |
6 | Li Z, Lian B, Chen J, Song D, Zhao Q. Systematic review and meta-analysis of splenectomy in gastrectomy for gastric carcinoma. Int J Surg 2019;68:104-113. DOI |
7 | Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810-1820. DOI |
8 | Yura M, Yoshikawa T, Otsuki S, Yamagata Y, Morita S, Katai H, et al. The therapeutic survival benefit of splenic hilar nodal dissection for advanced proximal gastric cancer invading the greater curvature. Ann Surg Oncol 2019;26:829-835. DOI |
9 | Nashimoto A, Yabusaki H, Matsuki A. The significance of splenectomy for advanced proximal gastric cancer. Int J Surg Oncol 2012;2012:301530. DOI |
10 | Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, et al. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer 2011;14:172-177. DOI |
11 | Hayashi T, Yoshikawa T, Kamiya A, Date K, Wada T, Otsuki S, et al. Is splenectomy for dissecting splenic hilar lymph nodes justified for scirrhous gastric cancer? Gastric Cancer 2020;23:922-926. DOI |
12 | Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol 2013;107:230-236. DOI |
13 | Kunisaki C, Makino H, Suwa H, Sato T, Oshima T, Nagano Y, et al. Impact of splenectomy in patients with gastric adenocarcinoma of the cardia. J Gastrointest Surg 2007;11:1039-1044. DOI |
14 | Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021;24:1-21. DOI |
15 | Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996;347:995-999. DOI |
16 | Otsuji E, Yamaguchi T, Sawai K, Okamoto K, Takahashi T. Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer 1999;79:1789-1793. DOI |
17 | Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg 2017;265:277-283. DOI |
18 | An JY, Kang TH, Choi MG, Noh JH, Sohn TS, Kim S. Borrmann type IV: an independent prognostic factor for survival in gastric cancer. J Gastrointest Surg 2008;12:1364-1369. DOI |
19 | Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112. DOI |
20 | Jung K, Park MI, Kim SE, Park SJ. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc 2016;49:336-345. DOI |
21 | Takizawa T, Iwasaki Y, Koike M. Distinctive features of linitis plastica type gastric carcinoma with reference to lymphangiosis carcinomatosa. Stomach Intest 1992;27:591-598. |
22 | Jafferbhoy S, Shiwani H, Rustum Q. Managing gastric linitis plastica: keep the scalpel sheathed. Sultan Qaboos Univ Med J 2013;13:451-453. |
23 | Schauer M, Peiper M, Theisen J, Knoefel W. Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment. Eur J Med Res 2011;16:29-33. DOI |
24 | Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82:346-351. DOI |
25 | Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11:439-449. DOI |
26 | Ohkura Y, Haruta S, Shindoh J, Tanaka T, Ueno M, Udagawa H. Efficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater curvature. World J Surg Oncol 2017;15:106. DOI |
27 | Maehara Y, Moriguchi S, Yoshida M, Takahashi I, Korenaga D, Sugimachi K. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 1991;67:3006-3009. DOI |
28 | Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006;93:559-563. DOI |
29 | Yokota T, Teshima S, Saito T, Kikuchi S, Kunii Y, Yamauchi H. Borrmann's type IV gastric cancer: clinicopathologic analysis. Can J Surg 1999;42:371-376. |
30 | National Cancer Institute. Cancer therapy evaluation program, common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 [Internet]. Bethesda (MD): National Cancer Institute; 2006 [cited 2021 Sep 23]. Available from: http://ctep.cancer.gov. |
31 | Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013;48:452-458. DOI |
32 | Maezawa Y, Aoyama T, Yamada T, Kano K, Hayashi T, Sato T, et al. Priority of lymph node dissection for proximal gastric cancer invading the greater curvature. Gastric Cancer 2018;21:569-572. DOI |
33 | Natsugoe S, Aiko T, Shimazu H. A detailed histological study on occult metastasis of the lymph nodes. Jpn J Surg 1991;21:528-532. DOI |
34 | Endo K, Sakurai M, Kusumoto E, Uehara H, Yamaguchi S, Tsutsumi N, et al. Biological significance of localized type IV scirrhous gastric cancer. Oncol Lett 2012;3:94-99. DOI |
35 | Candela FC, Urmacher C, Brennan MF. Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma. Cancer 1990;66:1828-1832. DOI |
![]() |